

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 5.53876996 |
| 2 | cellular potassium ion homeostasis (GO:0030007) | 5.26524755 |
| 3 | short-term memory (GO:0007614) | 5.17447189 |
| 4 | sodium ion export (GO:0071436) | 5.00240214 |
| 5 | potassium ion import (GO:0010107) | 4.90242410 |
| 6 | gamma-aminobutyric acid transport (GO:0015812) | 4.86983725 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.79420572 |
| 8 | alanine transport (GO:0032328) | 4.76083898 |
| 9 | vitamin A metabolic process (GO:0006776) | 4.73922594 |
| 10 | cerebellar granule cell differentiation (GO:0021707) | 4.37408765 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.31209427 |
| 12 | cellular sodium ion homeostasis (GO:0006883) | 4.27526964 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.26490174 |
| 14 | proline transport (GO:0015824) | 4.25043298 |
| 15 | L-amino acid import (GO:0043092) | 4.22269815 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.15178227 |
| 17 | righting reflex (GO:0060013) | 4.14047614 |
| 18 | synaptic vesicle maturation (GO:0016188) | 4.10387812 |
| 19 | cell communication by electrical coupling (GO:0010644) | 4.05898285 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.04895876 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.01565735 |
| 22 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.99570778 |
| 23 | amino acid import (GO:0043090) | 3.94525773 |
| 24 | neuronal action potential propagation (GO:0019227) | 3.94228736 |
| 25 | vocalization behavior (GO:0071625) | 3.94091809 |
| 26 | * glutamate receptor signaling pathway (GO:0007215) | 3.92490579 |
| 27 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.89078065 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.87740046 |
| 29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.87463546 |
| 30 | synaptic vesicle exocytosis (GO:0016079) | 3.86393729 |
| 31 | epithelial cilium movement (GO:0003351) | 3.82842195 |
| 32 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.80821101 |
| 33 | cilium movement (GO:0003341) | 3.75399618 |
| 34 | glutamate secretion (GO:0014047) | 3.72153945 |
| 35 | exploration behavior (GO:0035640) | 3.70124103 |
| 36 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.69179428 |
| 37 | membrane repolarization (GO:0086009) | 3.67386647 |
| 38 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.64696647 |
| 39 | response to auditory stimulus (GO:0010996) | 3.61841514 |
| 40 | potassium ion homeostasis (GO:0055075) | 3.58537803 |
| 41 | long-term memory (GO:0007616) | 3.57872726 |
| 42 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.56978953 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.54084913 |
| 44 | neurotransmitter secretion (GO:0007269) | 3.52964800 |
| 45 | auditory behavior (GO:0031223) | 3.51897309 |
| 46 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.50766895 |
| 47 | mesenchymal cell proliferation (GO:0010463) | 3.48018869 |
| 48 | neuron-neuron synaptic transmission (GO:0007270) | 3.46939352 |
| 49 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45783921 |
| 50 | * G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.45050347 |
| 51 | C4-dicarboxylate transport (GO:0015740) | 3.43141155 |
| 52 | intraciliary transport (GO:0042073) | 3.40614085 |
| 53 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.39883363 |
| 54 | dendrite morphogenesis (GO:0048813) | 3.32496878 |
| 55 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.29959357 |
| 56 | nonmotile primary cilium assembly (GO:0035058) | 3.29322453 |
| 57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.27643267 |
| 58 | diterpenoid biosynthetic process (GO:0016102) | 3.27286285 |
| 59 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.27277943 |
| 60 | inner ear receptor stereocilium organization (GO:0060122) | 3.27021876 |
| 61 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26587527 |
| 62 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.26369805 |
| 63 | L-serine transport (GO:0015825) | 3.25909391 |
| 64 | layer formation in cerebral cortex (GO:0021819) | 3.24857096 |
| 65 | cell differentiation in hindbrain (GO:0021533) | 3.23978665 |
| 66 | protein localization to synapse (GO:0035418) | 3.23148802 |
| 67 | limb bud formation (GO:0060174) | 3.21871048 |
| 68 | behavioral defense response (GO:0002209) | 3.21563747 |
| 69 | behavioral fear response (GO:0001662) | 3.21563747 |
| 70 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.21347472 |
| 71 | neuron cell-cell adhesion (GO:0007158) | 3.20937573 |
| 72 | response to pheromone (GO:0019236) | 3.20780105 |
| 73 | innervation (GO:0060384) | 3.19549401 |
| 74 | glycine transport (GO:0015816) | 3.18355690 |
| 75 | transmission of nerve impulse (GO:0019226) | 3.18338272 |
| 76 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.18248028 |
| 77 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.14369653 |
| 78 | regulation of synaptic vesicle transport (GO:1902803) | 3.09915255 |
| 79 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.08519557 |
| 80 | retinal ganglion cell axon guidance (GO:0031290) | 3.07522085 |
| 81 | auditory receptor cell stereocilium organization (GO:0060088) | 3.07025047 |
| 82 | neuromuscular process controlling balance (GO:0050885) | 3.06519571 |
| 83 | membrane repolarization during action potential (GO:0086011) | 3.05682189 |
| 84 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.05400731 |
| 85 | retinal cone cell development (GO:0046549) | 3.05365978 |
| 86 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04786884 |
| 87 | regulation of membrane repolarization (GO:0060306) | 3.04474852 |
| 88 | serotonin receptor signaling pathway (GO:0007210) | 3.01684420 |
| 89 | retina layer formation (GO:0010842) | 2.97825577 |
| 90 | neurotransmitter transport (GO:0006836) | 2.97795642 |
| 91 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94140660 |
| 92 | reflex (GO:0060004) | 2.92619190 |
| 93 | neuronal ion channel clustering (GO:0045161) | 2.90631386 |
| 94 | negative regulation of hormone metabolic process (GO:0032351) | 2.90383304 |
| 95 | retinal metabolic process (GO:0042574) | 2.89741926 |
| 96 | cilium organization (GO:0044782) | 2.88810793 |
| 97 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.88293781 |
| 98 | positive regulation of synapse maturation (GO:0090129) | 2.87840759 |
| 99 | protein targeting to vacuole (GO:0006623) | 2.87779970 |
| 100 | protein targeting to lysosome (GO:0006622) | 2.87779970 |
| 101 | establishment of protein localization to vacuole (GO:0072666) | 2.87779970 |
| 102 | postsynaptic membrane organization (GO:0001941) | 2.87019254 |
| 103 | acidic amino acid transport (GO:0015800) | 2.86516073 |
| 104 | secondary metabolite biosynthetic process (GO:0044550) | 2.86282723 |
| 105 | cilium assembly (GO:0042384) | 2.86002217 |
| 106 | behavioral response to cocaine (GO:0048148) | 2.85861999 |
| 107 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.85699389 |
| 108 | photoreceptor cell development (GO:0042461) | 2.85550118 |
| 109 | fear response (GO:0042596) | 2.84883010 |
| 110 | mechanosensory behavior (GO:0007638) | 2.84400149 |
| 111 | regulation of feeding behavior (GO:0060259) | 2.82925074 |
| 112 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.82920790 |
| 113 | cellular response to electrical stimulus (GO:0071257) | 2.82794191 |
| 114 | membrane hyperpolarization (GO:0060081) | 2.81433000 |
| 115 | positive regulation of amino acid transport (GO:0051957) | 2.80633511 |
| 116 | regulation of beta-amyloid formation (GO:1902003) | 2.80245032 |
| 117 | establishment of nucleus localization (GO:0040023) | 2.79473823 |
| 118 | smoothened signaling pathway (GO:0007224) | 2.79384118 |
| 119 | lateral sprouting from an epithelium (GO:0060601) | 2.79342006 |
| 120 | regulation of postsynaptic membrane potential (GO:0060078) | 2.78857380 |
| 121 | detection of light stimulus involved in visual perception (GO:0050908) | 2.78537229 |
| 122 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.78537229 |
| 123 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.78009498 |
| 124 | startle response (GO:0001964) | 2.77997987 |
| 125 | synaptic vesicle endocytosis (GO:0048488) | 2.77341040 |
| 126 | ketone body metabolic process (GO:1902224) | 2.76900074 |
| 127 | dendritic spine morphogenesis (GO:0060997) | 2.76280883 |
| 128 | regulation of synapse structural plasticity (GO:0051823) | 2.76266138 |
| 129 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.76011800 |
| 130 | type B pancreatic cell development (GO:0003323) | 2.75618923 |
| 131 | regulation of neurotransmitter levels (GO:0001505) | 2.75336051 |
| 132 | membrane depolarization during action potential (GO:0086010) | 2.74854935 |
| 133 | positive regulation of potassium ion transport (GO:0043268) | 2.74578219 |
| 134 | regulation of respiratory gaseous exchange (GO:0043576) | 2.74353300 |
| 135 | midbrain development (GO:0030901) | 2.73511392 |
| 136 | serine transport (GO:0032329) | 2.73438631 |
| 137 | neuromuscular process controlling posture (GO:0050884) | 2.73294383 |
| 138 | otic vesicle formation (GO:0030916) | 2.73287494 |
| 139 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.71432129 |
| 140 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.68391756 |
| 141 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.68210019 |
| 142 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.67697519 |
| 143 | eye photoreceptor cell development (GO:0042462) | 2.67532103 |
| 144 | negative chemotaxis (GO:0050919) | 2.67438666 |
| 145 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.66736378 |
| 146 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.64915828 |
| 147 | synapse assembly (GO:0007416) | 2.64850946 |
| 148 | negative regulation of sodium ion transport (GO:0010766) | 2.64402204 |
| 149 | positive regulation of membrane potential (GO:0045838) | 2.63151578 |
| 150 | axoneme assembly (GO:0035082) | 2.62113213 |
| 151 | presynaptic membrane assembly (GO:0097105) | 2.61813878 |
| 152 | regulation of synaptic plasticity (GO:0048167) | 2.60780893 |
| 153 | cilium morphogenesis (GO:0060271) | 2.60516427 |
| 154 | adult walking behavior (GO:0007628) | 2.60087641 |
| 155 | limb development (GO:0060173) | 2.60057117 |
| 156 | appendage development (GO:0048736) | 2.60057117 |
| 157 | cranial suture morphogenesis (GO:0060363) | 2.59372761 |
| 158 | neuron fate determination (GO:0048664) | 2.58942825 |
| 159 | neurotransmitter uptake (GO:0001504) | 2.58503233 |
| 160 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.57863887 |
| 161 | axonal fasciculation (GO:0007413) | 2.57863716 |
| 162 | long-term synaptic potentiation (GO:0060291) | 2.57702220 |
| 163 | neuromuscular process (GO:0050905) | 2.57558502 |
| 164 | regulation of cell communication by electrical coupling (GO:0010649) | 2.56743612 |
| 165 | protein localization to cilium (GO:0061512) | 2.55783993 |
| 166 | dorsal/ventral neural tube patterning (GO:0021904) | 2.54131530 |
| 167 | photoreceptor cell maintenance (GO:0045494) | 2.53788443 |
| 168 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.53641545 |
| 169 | axonemal dynein complex assembly (GO:0070286) | 2.52162152 |
| 170 | behavioral response to nicotine (GO:0035095) | 2.51724652 |
| 171 | central nervous system myelination (GO:0022010) | 2.50067011 |
| 172 | axon ensheathment in central nervous system (GO:0032291) | 2.50067011 |
| 173 | terpenoid biosynthetic process (GO:0016114) | 2.47918418 |
| 174 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.47895056 |
| 175 | platelet dense granule organization (GO:0060155) | 2.45769590 |
| 176 | branch elongation of an epithelium (GO:0060602) | 2.44096581 |
| 177 | positive regulation of meiosis (GO:0045836) | 2.43181702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.51848047 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27804556 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97377905 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.84423141 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.66931139 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56899852 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56899852 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53533911 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.53370330 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48912694 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.38310703 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35889672 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35423158 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31416413 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.30523040 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29787361 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24519603 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17046696 |
| 19 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.08109685 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.07710152 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06246952 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05248042 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04399481 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.04001829 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96000278 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95051790 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.92265677 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85975226 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.78180346 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78179730 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72723754 |
| 32 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.67781752 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64494542 |
| 34 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63369437 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62253660 |
| 36 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58760198 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.58441794 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58062503 |
| 39 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.57452554 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52333980 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50178746 |
| 42 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48111158 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.46450039 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45635091 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43350168 |
| 46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42180470 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41655632 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41429028 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40659909 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37396106 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36502821 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35487932 |
| 53 | AR_19668381_ChIP-Seq_PC3_Human | 1.33454104 |
| 54 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.31456767 |
| 55 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31080991 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31064593 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31064593 |
| 58 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30945428 |
| 59 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30402295 |
| 60 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30319420 |
| 61 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29350398 |
| 62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28568420 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27370845 |
| 64 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27027990 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.26984011 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26433129 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25670288 |
| 68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24954559 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24192607 |
| 70 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.23509976 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23154523 |
| 72 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22957368 |
| 73 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22487079 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21516093 |
| 75 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.19627155 |
| 76 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19409605 |
| 77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19080077 |
| 78 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.18679105 |
| 79 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16074395 |
| 80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14641225 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13671500 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12374609 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12273868 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12115869 |
| 85 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11953771 |
| 86 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11870959 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11749197 |
| 88 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11739999 |
| 89 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.10934985 |
| 90 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10861739 |
| 91 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10634212 |
| 92 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10188727 |
| 93 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09670308 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08855174 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08855174 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.07917338 |
| 97 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06997166 |
| 98 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06701634 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06701634 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05679090 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05625279 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05004403 |
| 103 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04834078 |
| 104 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04457197 |
| 105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04145444 |
| 106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03781470 |
| 107 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03593452 |
| 108 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.03115750 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02550354 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02397602 |
| 111 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01571481 |
| 112 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01468738 |
| 113 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00797954 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00618684 |
| 115 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99797196 |
| 116 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99707989 |
| 117 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99632080 |
| 118 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99405669 |
| 119 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99340176 |
| 120 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.99040456 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98530546 |
| 122 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98338843 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97468633 |
| 124 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.96857441 |
| 125 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96042364 |
| 126 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95039321 |
| 127 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94829272 |
| 128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93525962 |
| 129 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92614591 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92419439 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91673784 |
| 132 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91605309 |
| 133 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88115004 |
| 134 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87238986 |
| 135 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86971915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.84221318 |
| 2 | MP0003136_yellow_coat_color | 3.38532164 |
| 3 | MP0009046_muscle_twitch | 3.34011109 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.24634399 |
| 5 | MP0004270_analgesia | 3.08580802 |
| 6 | MP0001486_abnormal_startle_reflex | 2.72212897 |
| 7 | MP0004885_abnormal_endolymph | 2.68226741 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.63508591 |
| 9 | MP0005171_absent_coat_pigmentation | 2.61153567 |
| 10 | MP0003880_abnormal_central_pattern | 2.60269511 |
| 11 | MP0009745_abnormal_behavioral_response | 2.58501961 |
| 12 | MP0002064_seizures | 2.57189018 |
| 13 | MP0002102_abnormal_ear_morphology | 2.54692975 |
| 14 | MP0003879_abnormal_hair_cell | 2.53157020 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.41739291 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.39590655 |
| 17 | MP0002272_abnormal_nervous_system | 2.39362390 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.30533740 |
| 19 | MP0004858_abnormal_nervous_system | 2.29434768 |
| 20 | MP0010030_abnormal_orbit_morphology | 2.27342683 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.22819216 |
| 22 | MP0001485_abnormal_pinna_reflex | 2.18764206 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.17809431 |
| 24 | MP0008569_lethality_at_weaning | 2.11815968 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.08012356 |
| 26 | MP0005377_hearing/vestibular/ear_phenot | 2.02994797 |
| 27 | MP0003878_abnormal_ear_physiology | 2.02994797 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.95766346 |
| 29 | MP0003690_abnormal_glial_cell | 1.88731589 |
| 30 | MP0003122_maternal_imprinting | 1.86610034 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.80163419 |
| 32 | MP0002736_abnormal_nociception_after | 1.78316980 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.76546236 |
| 34 | MP0001502_abnormal_circadian_rhythm | 1.74001893 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.71849716 |
| 36 | MP0001963_abnormal_hearing_physiology | 1.63994995 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.61877822 |
| 38 | MP0003329_amyloid_beta_deposits | 1.61662443 |
| 39 | MP0003011_delayed_dark_adaptation | 1.60580502 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.59238615 |
| 41 | MP0003938_abnormal_ear_development | 1.55227717 |
| 42 | MP0003633_abnormal_nervous_system | 1.53460356 |
| 43 | MP0000778_abnormal_nervous_system | 1.52453646 |
| 44 | MP0001970_abnormal_pain_threshold | 1.50219001 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.50206737 |
| 46 | MP0002184_abnormal_innervation | 1.49051974 |
| 47 | MP0004142_abnormal_muscle_tone | 1.46927567 |
| 48 | MP0002234_abnormal_pharynx_morphology | 1.45060970 |
| 49 | MP0001299_abnormal_eye_distance/ | 1.42745797 |
| 50 | MP0001293_anophthalmia | 1.39244004 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.38257077 |
| 52 | MP0003631_nervous_system_phenotype | 1.37688657 |
| 53 | MP0005646_abnormal_pituitary_gland | 1.37395778 |
| 54 | MP0003632_abnormal_nervous_system | 1.34603461 |
| 55 | MP0002233_abnormal_nose_morphology | 1.33806210 |
| 56 | MP0005391_vision/eye_phenotype | 1.33130869 |
| 57 | MP0005253_abnormal_eye_physiology | 1.33047499 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.32615010 |
| 59 | MP0004924_abnormal_behavior | 1.32615010 |
| 60 | MP0006292_abnormal_olfactory_placode | 1.28987015 |
| 61 | MP0002229_neurodegeneration | 1.27487380 |
| 62 | MP0000026_abnormal_inner_ear | 1.23697469 |
| 63 | MP0000955_abnormal_spinal_cord | 1.23684673 |
| 64 | MP0002089_abnormal_postnatal_growth/wei | 1.23385557 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.21738752 |
| 66 | MP0003634_abnormal_glial_cell | 1.21020773 |
| 67 | MP0004043_abnormal_pH_regulation | 1.19094460 |
| 68 | MP0008004_abnormal_stomach_pH | 1.17277338 |
| 69 | MP0009384_cardiac_valve_regurgitation | 1.16673021 |
| 70 | MP0003937_abnormal_limbs/digits/tail_de | 1.15888415 |
| 71 | MP0000383_abnormal_hair_follicle | 1.15003255 |
| 72 | MP0000462_abnormal_digestive_system | 1.14867224 |
| 73 | MP0002638_abnormal_pupillary_reflex | 1.14515762 |
| 74 | MP0004811_abnormal_neuron_physiology | 1.13080708 |
| 75 | MP0002066_abnormal_motor_capabilities/c | 1.13021499 |
| 76 | MP0001346_abnormal_lacrimal_gland | 1.10891040 |
| 77 | MP0001984_abnormal_olfaction | 1.10508358 |
| 78 | MP0004742_abnormal_vestibular_system | 1.07723058 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 1.07626094 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 1.04367567 |
| 81 | MP0000516_abnormal_urinary_system | 1.04367567 |
| 82 | MP0003119_abnormal_digestive_system | 1.03722910 |
| 83 | MP0004147_increased_porphyrin_level | 1.01572990 |
| 84 | MP0002653_abnormal_ependyma_morphology | 0.99729690 |
| 85 | MP0000566_synostosis | 0.99610576 |
| 86 | MP0000920_abnormal_myelination | 0.99353953 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.98262599 |
| 88 | MP0001177_atelectasis | 0.98219015 |
| 89 | MP0003045_fibrosis | 0.98198699 |
| 90 | MP0002152_abnormal_brain_morphology | 0.97276833 |
| 91 | MP0000569_abnormal_digit_pigmentation | 0.96724642 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.93001695 |
| 93 | MP0001529_abnormal_vocalization | 0.92884164 |
| 94 | MP0003121_genomic_imprinting | 0.92036051 |
| 95 | MP0002752_abnormal_somatic_nervous | 0.91745923 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.90587574 |
| 97 | MP0005499_abnormal_olfactory_system | 0.90587574 |
| 98 | MP0000372_irregular_coat_pigmentation | 0.90068813 |
| 99 | MP0001286_abnormal_eye_development | 0.90055272 |
| 100 | MP0005197_abnormal_uvea_morphology | 0.88278110 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.88204395 |
| 102 | MP0004233_abnormal_muscle_weight | 0.88180940 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.88167935 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.87918872 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.87250997 |
| 106 | MP0005409_darkened_coat_color | 0.86755844 |
| 107 | MP0008789_abnormal_olfactory_epithelium | 0.86007155 |
| 108 | MP0002090_abnormal_vision | 0.85660182 |
| 109 | MP0003172_abnormal_lysosome_physiology | 0.85486225 |
| 110 | MP0002909_abnormal_adrenal_gland | 0.84998022 |
| 111 | MP0005187_abnormal_penis_morphology | 0.84252254 |
| 112 | MP0002697_abnormal_eye_size | 0.82697168 |
| 113 | MP0000647_abnormal_sebaceous_gland | 0.81923454 |
| 114 | MP0005408_hypopigmentation | 0.81801435 |
| 115 | MP0002254_reproductive_system_inflammat | 0.79454665 |
| 116 | MP0000537_abnormal_urethra_morphology | 0.78130050 |
| 117 | MP0003755_abnormal_palate_morphology | 0.76675380 |
| 118 | MP0003787_abnormal_imprinting | 0.76424327 |
| 119 | MP0003283_abnormal_digestive_organ | 0.75538632 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.72118038 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.71988459 |
| 122 | MP0000579_abnormal_nail_morphology | 0.71595672 |
| 123 | MP0000631_abnormal_neuroendocrine_gland | 0.71397334 |
| 124 | MP0000751_myopathy | 0.69117620 |
| 125 | MP0001324_abnormal_eye_pigmentation | 0.68648700 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.68257250 |
| 127 | MP0004085_abnormal_heartbeat | 0.66677356 |
| 128 | MP0000604_amyloidosis | 0.64739474 |
| 129 | MP0005195_abnormal_posterior_eye | 0.64492710 |
| 130 | MP0002108_abnormal_muscle_morphology | 0.63543813 |
| 131 | MP0003646_muscle_fatigue | 0.62572072 |
| 132 | MP0002938_white_spotting | 0.61375445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.14816015 |
| 2 | Action tremor (HP:0002345) | 5.09186060 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 4.63534300 |
| 4 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.63534300 |
| 5 | Aplasia of the phalanges of the hand (HP:0009802) | 4.63534300 |
| 6 | True hermaphroditism (HP:0010459) | 4.28731657 |
| 7 | Pancreatic fibrosis (HP:0100732) | 4.17778142 |
| 8 | Focal seizures (HP:0007359) | 4.07171108 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.96721854 |
| 10 | Molar tooth sign on MRI (HP:0002419) | 3.91262610 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.91262610 |
| 12 | Pancreatic cysts (HP:0001737) | 3.77280119 |
| 13 | Hemiparesis (HP:0001269) | 3.76648109 |
| 14 | Myokymia (HP:0002411) | 3.59094533 |
| 15 | Epileptic encephalopathy (HP:0200134) | 3.46100617 |
| 16 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.40874351 |
| 17 | Abnormal ciliary motility (HP:0012262) | 3.36834879 |
| 18 | Visual hallucinations (HP:0002367) | 3.31161335 |
| 19 | Megalencephaly (HP:0001355) | 3.30199592 |
| 20 | Abnormality of binocular vision (HP:0011514) | 3.19373767 |
| 21 | Diplopia (HP:0000651) | 3.19373767 |
| 22 | Medial flaring of the eyebrow (HP:0010747) | 3.18033498 |
| 23 | Nephronophthisis (HP:0000090) | 3.17279288 |
| 24 | Hemiplegia (HP:0002301) | 3.14994488 |
| 25 | Gait imbalance (HP:0002141) | 3.13508503 |
| 26 | Occipital encephalocele (HP:0002085) | 3.10007164 |
| 27 | Febrile seizures (HP:0002373) | 3.08043106 |
| 28 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.05904960 |
| 29 | Mixed hearing impairment (HP:0000410) | 3.04587576 |
| 30 | Cystic liver disease (HP:0006706) | 3.00102765 |
| 31 | Dysdiadochokinesis (HP:0002075) | 2.99968367 |
| 32 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.99021295 |
| 33 | Vaginal atresia (HP:0000148) | 2.97078792 |
| 34 | Genital tract atresia (HP:0001827) | 2.93104456 |
| 35 | Hyperactive renin-angiotensin system (HP:0000841) | 2.90991332 |
| 36 | Congenital primary aphakia (HP:0007707) | 2.90372409 |
| 37 | Concave nail (HP:0001598) | 2.89588017 |
| 38 | Rhinitis (HP:0012384) | 2.87471686 |
| 39 | Ventricular fibrillation (HP:0001663) | 2.86823242 |
| 40 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.83294782 |
| 41 | Hypoplasia of the fovea (HP:0007750) | 2.83294782 |
| 42 | Gaze-evoked nystagmus (HP:0000640) | 2.82919843 |
| 43 | Atonic seizures (HP:0010819) | 2.81083330 |
| 44 | Chronic hepatic failure (HP:0100626) | 2.81006400 |
| 45 | Blue irides (HP:0000635) | 2.80018849 |
| 46 | Sclerocornea (HP:0000647) | 2.76034325 |
| 47 | Metabolic alkalosis (HP:0200114) | 2.75260222 |
| 48 | Generalized tonic-clonic seizures (HP:0002069) | 2.72948096 |
| 49 | Postural instability (HP:0002172) | 2.70793352 |
| 50 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.69060745 |
| 51 | Truncal ataxia (HP:0002078) | 2.66911663 |
| 52 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.66390852 |
| 53 | Postaxial foot polydactyly (HP:0001830) | 2.64975504 |
| 54 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.64037376 |
| 55 | Intention tremor (HP:0002080) | 2.63765456 |
| 56 | Genetic anticipation (HP:0003743) | 2.63313754 |
| 57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.58127562 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.56908344 |
| 59 | Synostosis involving the elbow (HP:0003938) | 2.54106187 |
| 60 | Humeroradial synostosis (HP:0003041) | 2.54106187 |
| 61 | Absence seizures (HP:0002121) | 2.53636377 |
| 62 | Dialeptic seizures (HP:0011146) | 2.51116551 |
| 63 | Anencephaly (HP:0002323) | 2.49547703 |
| 64 | Optic nerve hypoplasia (HP:0000609) | 2.49327302 |
| 65 | Hypokalemic alkalosis (HP:0001949) | 2.48376375 |
| 66 | Polyuria (HP:0000103) | 2.48067829 |
| 67 | Abnormality of the renal medulla (HP:0100957) | 2.47917568 |
| 68 | Scanning speech (HP:0002168) | 2.44919212 |
| 69 | Midline defect of the nose (HP:0004122) | 2.44753667 |
| 70 | Broad-based gait (HP:0002136) | 2.43173402 |
| 71 | Abnormality of the labia minora (HP:0012880) | 2.40872569 |
| 72 | Status epilepticus (HP:0002133) | 2.38791019 |
| 73 | Attenuation of retinal blood vessels (HP:0007843) | 2.37128243 |
| 74 | Abnormal eating behavior (HP:0100738) | 2.35408805 |
| 75 | Scotoma (HP:0000575) | 2.34497834 |
| 76 | Postaxial hand polydactyly (HP:0001162) | 2.34069042 |
| 77 | Preaxial hand polydactyly (HP:0001177) | 2.33954865 |
| 78 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.32852645 |
| 79 | Absent speech (HP:0001344) | 2.32633004 |
| 80 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.31325485 |
| 81 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.31325485 |
| 82 | Arterial tortuosity (HP:0005116) | 2.27190438 |
| 83 | Dysmetria (HP:0001310) | 2.24527770 |
| 84 | Postural tremor (HP:0002174) | 2.23918753 |
| 85 | Abnormality of the fovea (HP:0000493) | 2.23289112 |
| 86 | Abnormality of macular pigmentation (HP:0008002) | 2.21689136 |
| 87 | Prolonged QT interval (HP:0001657) | 2.19502017 |
| 88 | Depression (HP:0000716) | 2.19484619 |
| 89 | Congenital hepatic fibrosis (HP:0002612) | 2.16526093 |
| 90 | Congenital stationary night blindness (HP:0007642) | 2.16363978 |
| 91 | Alacrima (HP:0000522) | 2.16102925 |
| 92 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.15246812 |
| 93 | Impaired smooth pursuit (HP:0007772) | 2.14489600 |
| 94 | Split foot (HP:0001839) | 2.13889658 |
| 95 | Dysmetric saccades (HP:0000641) | 2.10861560 |
| 96 | Decreased central vision (HP:0007663) | 2.10244150 |
| 97 | Hypopigmentation of the fundus (HP:0007894) | 2.07911045 |
| 98 | Bilateral microphthalmos (HP:0007633) | 2.06723083 |
| 99 | Hyperaldosteronism (HP:0000859) | 2.02671329 |
| 100 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.02315586 |
| 101 | Abdominal situs inversus (HP:0003363) | 2.02305183 |
| 102 | Abnormality of abdominal situs (HP:0011620) | 2.02305183 |
| 103 | Bell-shaped thorax (HP:0001591) | 2.01997253 |
| 104 | Vascular tortuosity (HP:0004948) | 2.01960487 |
| 105 | Poor coordination (HP:0002370) | 1.99608758 |
| 106 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.99550519 |
| 107 | Abnormality of the dental pulp (HP:0006479) | 1.98680935 |
| 108 | Tubular atrophy (HP:0000092) | 1.98483301 |
| 109 | Choroideremia (HP:0001139) | 1.97874202 |
| 110 | Vitreoretinal degeneration (HP:0000655) | 1.96728468 |
| 111 | Aqueductal stenosis (HP:0002410) | 1.95931792 |
| 112 | Keratoconus (HP:0000563) | 1.95696357 |
| 113 | Increased corneal curvature (HP:0100692) | 1.95696357 |
| 114 | Epiphyseal dysplasia (HP:0002656) | 1.95468876 |
| 115 | Neurofibrillary tangles (HP:0002185) | 1.94730327 |
| 116 | Bile duct proliferation (HP:0001408) | 1.94012648 |
| 117 | Abnormal biliary tract physiology (HP:0012439) | 1.94012648 |
| 118 | Abnormal urine output (HP:0012590) | 1.92991092 |
| 119 | Abnormality of renin-angiotensin system (HP:0000847) | 1.91882875 |
| 120 | Polydipsia (HP:0001959) | 1.91768578 |
| 121 | Abnormal drinking behavior (HP:0030082) | 1.91768578 |
| 122 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.89492916 |
| 123 | Cutaneous finger syndactyly (HP:0010554) | 1.88149677 |
| 124 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.87761241 |
| 125 | Hepatoblastoma (HP:0002884) | 1.86962913 |
| 126 | Abnormality of permanent molar morphology (HP:0011071) | 1.86222967 |
| 127 | Abnormality of the dental root (HP:0006486) | 1.86222967 |
| 128 | Taurodontia (HP:0000679) | 1.86222967 |
| 129 | Neoplasm of the heart (HP:0100544) | 1.84527032 |
| 130 | Hypoplastic nipples (HP:0002557) | 1.83937079 |
| 131 | Trigonocephaly (HP:0000243) | 1.83891650 |
| 132 | Abnormal auditory evoked potentials (HP:0006958) | 1.82939695 |
| 133 | Hyperglycinemia (HP:0002154) | 1.82365067 |
| 134 | Male pseudohermaphroditism (HP:0000037) | 1.82174178 |
| 135 | Furrowed tongue (HP:0000221) | 1.81589651 |
| 136 | Abnormality of the renal cortex (HP:0011035) | 1.81296621 |
| 137 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.81237297 |
| 138 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.81164670 |
| 139 | Abnormality of the pubic bones (HP:0003172) | 1.81109913 |
| 140 | Macular degeneration (HP:0000608) | 1.81000765 |
| 141 | Drooling (HP:0002307) | 1.80346907 |
| 142 | Excessive salivation (HP:0003781) | 1.80346907 |
| 143 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.79712907 |
| 144 | Limb dystonia (HP:0002451) | 1.79466595 |
| 145 | Mutism (HP:0002300) | 1.78892397 |
| 146 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.78730459 |
| 147 | Narrow forehead (HP:0000341) | 1.78349394 |
| 148 | Abnormality of molar (HP:0011077) | 1.78100914 |
| 149 | Abnormality of molar morphology (HP:0011070) | 1.78100914 |
| 150 | Abolished electroretinogram (ERG) (HP:0000550) | 1.77550038 |
| 151 | Pheochromocytoma (HP:0002666) | 1.77546926 |
| 152 | Ankle clonus (HP:0011448) | 1.76130564 |
| 153 | Tetraplegia (HP:0002445) | 1.75931918 |
| 154 | Bifid tongue (HP:0010297) | 1.75928317 |
| 155 | Stomach cancer (HP:0012126) | 1.75897014 |
| 156 | Poor eye contact (HP:0000817) | 1.73311607 |
| 157 | Abnormal social behavior (HP:0012433) | 1.73067757 |
| 158 | Impaired social interactions (HP:0000735) | 1.73067757 |
| 159 | Clumsiness (HP:0002312) | 1.70691166 |
| 160 | Stereotypic behavior (HP:0000733) | 1.69455691 |
| 161 | Macroorchidism (HP:0000053) | 1.69451998 |
| 162 | Long nose (HP:0003189) | 1.69434971 |
| 163 | Narrow nasal bridge (HP:0000446) | 1.69057223 |
| 164 | Anteriorly placed anus (HP:0001545) | 1.68534612 |
| 165 | Bradykinesia (HP:0002067) | 1.65840477 |
| 166 | Abnormality of the lower motor neuron (HP:0002366) | 1.65347521 |
| 167 | Decreased lacrimation (HP:0000633) | 1.65331612 |
| 168 | Abnormality of the diencephalon (HP:0010662) | 1.64080944 |
| 169 | Peripheral hypomyelination (HP:0007182) | 1.63109752 |
| 170 | Anophthalmia (HP:0000528) | 1.62198226 |
| 171 | Anxiety (HP:0000739) | 1.60990026 |
| 172 | Abnormal EKG (HP:0003115) | 1.59249447 |
| 173 | Turricephaly (HP:0000262) | 1.57905278 |
| 174 | Increased circulating renin level (HP:0000848) | 1.57659679 |
| 175 | Polyphagia (HP:0002591) | 1.57347619 |
| 176 | Spastic gait (HP:0002064) | 1.57226037 |
| 177 | Hyperventilation (HP:0002883) | 1.56320484 |
| 178 | Cerebral inclusion bodies (HP:0100314) | 1.56070838 |
| 179 | Abnormality of the lacrimal duct (HP:0011481) | 1.54053317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.34622436 |
| 2 | NTRK3 | 3.75681613 |
| 3 | FRK | 3.22182625 |
| 4 | PRKD3 | 3.21664578 |
| 5 | NTRK2 | 2.73231712 |
| 6 | PASK | 2.60669820 |
| 7 | MAP3K4 | 2.58524581 |
| 8 | MAP3K9 | 2.50601258 |
| 9 | MARK1 | 2.40974571 |
| 10 | EPHA4 | 2.39444607 |
| 11 | DDR2 | 2.33075632 |
| 12 | WNK3 | 2.20360518 |
| 13 | MAP2K7 | 2.20178429 |
| 14 | PHKG2 | 2.15223284 |
| 15 | PHKG1 | 2.15223284 |
| 16 | STK38L | 2.03474398 |
| 17 | LMTK2 | 1.89080832 |
| 18 | MINK1 | 1.87246165 |
| 19 | CAMKK1 | 1.73759699 |
| 20 | WNK1 | 1.68399936 |
| 21 | SGK2 | 1.67182723 |
| 22 | MAPK13 | 1.66002899 |
| 23 | RIPK1 | 1.65499215 |
| 24 | PAK6 | 1.59782491 |
| 25 | CASK | 1.56232510 |
| 26 | NTRK1 | 1.55568217 |
| 27 | STK38 | 1.54530568 |
| 28 | CAMKK2 | 1.50799116 |
| 29 | SGK3 | 1.48740702 |
| 30 | NUAK1 | 1.44589531 |
| 31 | SGK223 | 1.44449155 |
| 32 | SGK494 | 1.44449155 |
| 33 | DAPK2 | 1.41594747 |
| 34 | MAP2K4 | 1.40991864 |
| 35 | BMPR1B | 1.37036773 |
| 36 | LATS1 | 1.29678573 |
| 37 | CAMK1G | 1.29448500 |
| 38 | PRKCG | 1.28599192 |
| 39 | CDK8 | 1.23680814 |
| 40 | CDK5 | 1.23275430 |
| 41 | FGFR2 | 1.20601787 |
| 42 | MAP4K2 | 1.18121710 |
| 43 | PRKCH | 1.17521739 |
| 44 | INSRR | 1.13331542 |
| 45 | CSNK1G1 | 1.06561857 |
| 46 | RIPK4 | 1.04523988 |
| 47 | EPHA3 | 1.01909636 |
| 48 | SIK1 | 1.01457598 |
| 49 | ADRBK2 | 0.99212600 |
| 50 | GRK1 | 0.96787694 |
| 51 | PRPF4B | 0.96292530 |
| 52 | RET | 0.93911881 |
| 53 | STK39 | 0.93719426 |
| 54 | SIK2 | 0.89983754 |
| 55 | KSR2 | 0.89869936 |
| 56 | CDC42BPA | 0.88686013 |
| 57 | MET | 0.88130458 |
| 58 | SGK1 | 0.87857212 |
| 59 | TSSK6 | 0.86269412 |
| 60 | PTK2B | 0.85009852 |
| 61 | MAP3K13 | 0.83924124 |
| 62 | WNK4 | 0.83277731 |
| 63 | NEK6 | 0.81988642 |
| 64 | TGFBR1 | 0.81175003 |
| 65 | STK24 | 0.81091823 |
| 66 | KSR1 | 0.78883640 |
| 67 | CAMK1 | 0.78848489 |
| 68 | STK16 | 0.78597150 |
| 69 | PLK2 | 0.77662123 |
| 70 | CAMK2A | 0.77505285 |
| 71 | MAP3K12 | 0.77233326 |
| 72 | MAP3K6 | 0.76232988 |
| 73 | MAP3K7 | 0.75091729 |
| 74 | PRKCE | 0.74967151 |
| 75 | PNCK | 0.74919233 |
| 76 | TYRO3 | 0.74759122 |
| 77 | MARK2 | 0.74732918 |
| 78 | PINK1 | 0.74522005 |
| 79 | UHMK1 | 0.74138717 |
| 80 | MST1R | 0.74043379 |
| 81 | AKT3 | 0.73422330 |
| 82 | DYRK2 | 0.72303153 |
| 83 | GRK5 | 0.72256392 |
| 84 | STK11 | 0.71453373 |
| 85 | CSNK1G3 | 0.71408337 |
| 86 | ALK | 0.68774025 |
| 87 | PRKACB | 0.67897984 |
| 88 | CAMK1D | 0.67318596 |
| 89 | DYRK1A | 0.65591337 |
| 90 | CSNK1A1L | 0.64400049 |
| 91 | CAMK4 | 0.63696981 |
| 92 | ERBB3 | 0.63149374 |
| 93 | MELK | 0.62785124 |
| 94 | FGFR1 | 0.62488916 |
| 95 | BCKDK | 0.62118961 |
| 96 | NLK | 0.61489877 |
| 97 | MAP3K2 | 0.61116168 |
| 98 | PRKACA | 0.60806686 |
| 99 | MAPK12 | 0.59824034 |
| 100 | FES | 0.58367229 |
| 101 | PKN1 | 0.58017431 |
| 102 | RPS6KA3 | 0.55152525 |
| 103 | PAK3 | 0.54819992 |
| 104 | BMX | 0.54647504 |
| 105 | OXSR1 | 0.53832685 |
| 106 | CDK19 | 0.53488923 |
| 107 | PDK1 | 0.53192401 |
| 108 | CAMK2B | 0.53066812 |
| 109 | DMPK | 0.50714030 |
| 110 | CAMK2G | 0.49554281 |
| 111 | DAPK1 | 0.49343599 |
| 112 | MAPK10 | 0.49117287 |
| 113 | PRKCZ | 0.47606045 |
| 114 | PDPK1 | 0.46929549 |
| 115 | STK3 | 0.46835318 |
| 116 | MKNK1 | 0.46787915 |
| 117 | CDK15 | 0.45322262 |
| 118 | CSNK1D | 0.45250317 |
| 119 | CAMK2D | 0.44675297 |
| 120 | PRKD2 | 0.44508093 |
| 121 | BCR | 0.43776628 |
| 122 | MKNK2 | 0.43620035 |
| 123 | CDK18 | 0.42801218 |
| 124 | ERBB2 | 0.42633662 |
| 125 | PRKG1 | 0.42381499 |
| 126 | PRKAA1 | 0.42379857 |
| 127 | PLK3 | 0.42147163 |
| 128 | FGFR3 | 0.41715519 |
| 129 | MUSK | 0.41388199 |
| 130 | TLK1 | 0.41310305 |
| 131 | MAPK15 | 0.40997984 |
| 132 | ROCK2 | 0.40817196 |
| 133 | EPHB2 | 0.40717645 |
| 134 | PRKCA | 0.40343404 |
| 135 | CSNK1G2 | 0.40311459 |
| 136 | LATS2 | 0.40016059 |
| 137 | HIPK2 | 0.37673085 |
| 138 | CSNK1A1 | 0.37642601 |
| 139 | PRKCB | 0.37609523 |
| 140 | MAPK7 | 0.37557170 |
| 141 | ZAK | 0.37333524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.48518428 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.58044047 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.54213651 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.45991580 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.45639935 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.38414291 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.34524493 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.29094646 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.22150134 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.20840809 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.19413884 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.13571168 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05223293 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.04103559 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.02111059 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.99570004 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.89366440 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.88122119 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.84677673 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80544762 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.70419202 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.65422537 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60881042 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.58245876 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.52038224 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50326776 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46354938 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.46331371 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.44240684 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43397962 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.38357469 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.33626233 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.33494910 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33372641 |
| 35 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.33133347 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32740629 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.31566211 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27699988 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27624655 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27178047 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25956820 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.23742467 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.20456017 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.20258202 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19837139 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19097063 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.17929231 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17406552 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16278787 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.15375424 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.15107147 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13732460 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 1.12888268 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12600441 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.10716413 |
| 56 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09057854 |
| 57 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08906185 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 1.08016778 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 1.07689773 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05233090 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04106829 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02531738 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02498139 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00913999 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00895173 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00637305 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00200469 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98604075 |
| 69 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.98365748 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97819756 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97797029 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96703188 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94540244 |
| 74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94450895 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91547996 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91541872 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91377631 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87720213 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.87519532 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.87286376 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.86494194 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84110249 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83669165 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80071112 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77934685 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.77200039 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74237423 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73846761 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72104125 |
| 90 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71506273 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70967912 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67979884 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.67944669 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67055458 |
| 95 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.65984460 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64733946 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64539018 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63047952 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61705859 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61332123 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61226829 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60749146 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60592667 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59853221 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56445322 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56219073 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56182072 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55434723 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54438833 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53172195 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52894285 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51786196 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50975239 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49562284 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.49006645 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47821047 |
| 117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47324864 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46901952 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46538402 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44900397 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43671026 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42120588 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41585538 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41532832 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40738033 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40396644 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39990424 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37541680 |
| 129 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35951858 |
| 130 | Melanoma_Homo sapiens_hsa05218 | 0.35291053 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34178482 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34026996 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.31727165 |
| 134 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31592353 |
| 135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30751241 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.30457453 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30348394 |
| 138 | Lysosome_Homo sapiens_hsa04142 | 0.30292458 |
| 139 | Lysine degradation_Homo sapiens_hsa00310 | 0.29394767 |

